| Ident. | Authors (with country if any) | Title |
|---|
| 000002 (2015) |
Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
| 000004 (2015) |
Miho Murata [Japon] ; Kazuko Hasegawa [Japon] ; Ichiro Kanazawa [Japon] ; Junichi Fukasaka [Japon] ; Kenji Kochi [Japon] ; Rieko Shimazu [Japon] | Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study. |
| 000005 (2015) |
Andrew Singleton [États-Unis] | X-linked Parkinson's disease. |
| 000007 (2015) |
Alastair J. Noyce ; Niccolo E. Mencacci ; Anette Schrag ; Jonathan P. Bestwick [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Andrew J. Lees ; John Hardy | Web-based assessment of Parkinson's prodromal markers identifies GBA variants. |
| 000008 (2015) |
Liyong Wang [États-Unis] ; Marian L. Evatt ; Lizmarie G. Maldonado ; William R. Perry ; James C. Ritchie ; Gary W. Beecham ; Eden R. Martin ; Jonathan L. Haines ; Margaret A. Pericak-Vance ; Jeffery M. Vance ; William K. Scott | Vitamin D from different sources is inversely associated with Parkinson disease. |
| 000014 (2015) |
S. Thobois [France] | USP30: a new promising target for Parkinson's disease? |
| 000017 (2015) |
Maja Kojovic [Royaume-Uni] ; Panagiotis Kassavetis [Royaume-Uni] ; Matteo Bologna [Italie] ; Isabel Pareés [Royaume-Uni] ; Ignacio Rubio-Agusti [Espagne] ; Alfredo Beraredelli [Italie] ; Mark J. Edwards [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression? |
| 000018 (2015) |
Maurits Van Den Noort [Corée du Sud] ; Peggy Bosch [Corée du Sud] ; Sujung Yeo [Corée du Sud] ; Sabina Lim [Corée du Sud] | Transcranial Magnetic Stimulation for Parkinson's Disease. |
| 000019 (2015) |
Roberto Erro [Royaume-Uni] ; Paolo Barone [Italie] | Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study. |
| 000028 (2015) |
David J. Burn | The treatment of mild cognitive impairment associated with Parkinson's disease. |
| 000032 (2015) |
Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten | The significance of motor (a)symmetry in Parkinson's disease. |
| 000033 (2015) |
Jin-Sung Park [Australie] ; Nicholas F. Blair [Australie] ; Carolyn M. Sue [Australie] | The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms. |
| 000035 (2015) |
Joaquin A. Vizcarra [Pérou] ; Hilary E. Wilson-Perez ; Alberto J. Espay | The power in numbers: gut microbiota in Parkinson's disease. |
| 000036 (2015) |
Claustre Pont-Sunyer [Espagne] ; Anna Hotter ; Carles Gaig ; Klaus Seppi ; Yaroslau Compta ; Regina Katzenschlager ; Natalia Mas ; Dominik Hofeneder ; Thomas Brücke ; Angels Bayés ; Karoline Wenzel ; Jon Infante ; Heidemarie Zach ; Walter Pirker ; Ignacio J. Posada ; Ramiro Álvarez ; Lourdes Ispierto ; Oriol De Fàbregues ; Antoni Callén ; Antoni Palasí ; Miquel Aguilar ; Maria José Martí ; Francesc Valldeoriola ; Manel Salamero ; Werner Poewe [Autriche] ; Eduardo Tolosa | The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). |
| 000038 (2015) |
Antonio Cerasa [Italie] ; Giulia Donzuso [Italie] ; Maurizio Morelli [Italie] ; Graziella Mangone [Italie] ; Maria Salsone [Italie] ; Luca Passamonti [Italie] ; Antonio Augimeri [Italie] ; Gennarina Arabia [Italie] ; Aldo Quattrone [Italie] | The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias. |
| 000039 (2015) |
Stanley Fahn [États-Unis] | The medical treatment of Parkinson disease from James Parkinson to George Cotzias. |
| 000042 (2015) |
Hasmet A. Hanagasi [Turquie] | The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. |
| 000045 (2015) |
Liana S. Rosenthal [États-Unis] ; Daniel Drake [États-Unis] ; Roy N. Alcalay [États-Unis] ; Debra Babcock [États-Unis] ; F Dubois Bowman [États-Unis] ; Alice Chen-Plotkin [États-Unis] ; Ted M. Dawson [États-Unis] ; Richard B. Dewey [États-Unis] ; Dwight C. German [États-Unis] ; Xuemei Huang [États-Unis] ; Barry Landin [États-Unis] ; Matthew Mcauliffe [États-Unis] ; Vladislav A. Petyuk [États-Unis] ; Clemens R. Scherzer [États-Unis] ; Coryse St Hillaire-Clarke [États-Unis] ; Beth-Anne Sieber [États-Unis] ; Margaret Sutherland [États-Unis] ; Chi Tarn [États-Unis] ; Andrew West [États-Unis] ; David Vaillancourt [États-Unis] ; Jing Zhang [États-Unis] ; Katrina Gwinn [États-Unis] | The NINDS Parkinson's disease biomarkers program. |
| 000049 (2015) |
Kishore Raj Kumar | Targeting glucocerebrosidase: Reduced enzymatic activity and Parkinson's disease. |
| 000052 (2015) |
Joseph M. Masters [Royaume-Uni] ; Jonathan Bestwick [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni] ; Gavin Giovannoni [Royaume-Uni] ; Gordon B. Proctor [Royaume-Uni] ; Alastair J. Noyce [Royaume-Uni] | Systematic review and meta-analysis of salivary protein concentration in Parkinson's disease. |
| 000053 (2015) |
Nika Zorko [Slovénie] ; Maja Kojovic [Slovénie] ; Dusan Flisar [Slovénie] ; Zvezdan Pirtosek [Slovénie] ; Milica Gregoric Kramberger [Slovénie] | Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel. |
| 000054 (2015) |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie] | Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease. |
| 000058 (2015) |
Sofia Reimão [Portugal] ; Patrícia Pita Lobo [Portugal] ; Dulce Neutel [Portugal] ; Leonor Correia Guedes [Portugal] ; Miguel Coelho [Portugal] ; Mário M. Rosa [Portugal] ; Pedro Azevedo [Portugal] ; Joana Ferreira [Portugal] ; Daisy Abreu [Portugal] ; Nilza Gonçalves [Portugal] ; Rita G. Nunes [Portugal] ; Jorge Campos [Portugal] ; Joaquim J. Ferreira [Portugal] | Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease. |
| 000062 (2015) |
Neha Shah [États-Unis] ; Kirk A. Frey [États-Unis] ; Martijn L T M Müller [États-Unis] ; Myria Petrou [États-Unis] ; Vikas Kotagal [États-Unis] ; Robert A. Koeppe [États-Unis] ; Peter J H. Scott [États-Unis] ; Roger L. Albin [États-Unis] ; Nicolaas I. Bohnen [États-Unis] | Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease. |
| 000064 (2015) |
Xuemei Huang [États-Unis] ; Alvaro Alonso ; Xuguang Guo ; David M. Umbach ; Maya L. Lichtenstein ; Christie M. Ballantyne ; Richard B. Mailman ; Thomas H. Mosley ; Honglei Chen | Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. |
| 000068 (2015) |
Maria Pia Giannoccaro [Italie] ; Vincenzo Donadio [Italie] ; Alex Incensi [Italie] ; Fabio Pizza [Italie] ; Ernesto Cason [Italie] ; Vitantonio Di Stasi [Italie] ; Paolo Martinelli [Italie] ; Cesa Scaglione [Italie] ; Sabina Capellari [Italie] ; Giorgio Treglia [Suisse] ; Rocco Liguori [Italie] | Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: a comparative study. |
| 000069 (2015) |
Perdita Cheshire [Australie] ; Scott Ayton [Australie] ; Kelly L. Bertram [Australie] ; Helen Ling [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Catriona Mclean [Australie] ; Glenda M. Halliday [Australie] ; Sean S. O'Sullivan [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David I. Finkelstein [Australie] ; Elsdon Storey [Australie] ; David R. Williams [Australie] | Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias. |
| 000072 (2015) |
Monika Pötter-Nerger [Australie] ; Sendhil Govender ; Günther Deuschl ; Jens Volkmann ; J G Colebatch | Selective changes of ocular vestibular myogenic potentials in Parkinson's disease. |
| 000073 (2015) |
Caroline Williams-Gray [Royaume-Uni] | Seeing Is Believing: Alpha-Synuclein Oligomers in Parkinson's Disease Brain. |
| 000075 (2015) |
Eugenia Mamikonyan [États-Unis] ; Sharon X. Xie [États-Unis] ; Emilie Melvin [États-Unis] ; Daniel Weintraub [États-Unis] | Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study. |
| 000076 (2015) |
Hugo Cesar Baggio [Espagne] ; Bàrbara Segura ; Jose Luis Garrido-Millan ; Maria-José Marti ; Yaroslau Compta ; Francesc Valldeoriola ; Eduardo Tolosa ; Carme Junque | Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy. |
| 000083 (2015) |
Hubert H. Fernandez [États-Unis] ; David G. Standaert [États-Unis] ; Krai Chatamra [États-Unis] ; Janet A. Benesh [États-Unis] | Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel. |
| 000084 (2015) |
Christine R. Swanson [États-Unis] ; Roy N. Alcalay [États-Unis] ; Alice Chen-Plotkin [États-Unis] | Reply to letter: Plasma fasting cholesterol profiles and age at onset in Parkinson's disease. |
| 000088 (2015) |
Maja Kojovic [Royaume-Uni] ; Matteo Bologna [Italie] ; Mark J. Edwards [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Reply to "Transcranial Magnetic Stimulation for Parkinson's Disease". |
| 000089 (2015) |
Anosha Zanjani [Canada] ; Konstantine K. Zakzanis [Canada] ; Zafiris J. Daskalakis [Canada] ; Robert Chen [Canada] | Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature. |
| 000090 (2015) |
Matthew J. Barrett [États-Unis] ; Nicholas E. Hac ; Guofen Yan ; Madaline B. Harrison ; G Frederick Wooten | Relationship of age of onset and family history in Parkinson disease. |
| 000093 (2015) |
Friederike Sixel-Döring [Allemagne] ; Katja Lohmann ; Christine Klein ; Claudia Trenkwalder ; Brit Mollenhauer | REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations. |
| 000095 (2015) |
Ronald B. Postuma [Canada] ; Charles H. Adler [États-Unis] ; Brittany N. Dugger [États-Unis] ; Joseph G. Hentz [États-Unis] ; Holly A. Shill [États-Unis] ; Erika Driver-Dunckley [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Sandra A. Jacobson [États-Unis] ; Christine M. Belden [États-Unis] ; Lucia I. Sue [États-Unis] ; Geidy Serrano [États-Unis] ; Thomas G. Beach [États-Unis] | REM sleep behavior disorder and neuropathology in Parkinson's disease. |
| 000097 (2015) |
Guangwei Du [États-Unis] ; Tian Liu [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Lan Kong [États-Unis] ; Yi Wang [États-Unis] ; James Connor [États-Unis] ; Richard B. Mailman [États-Unis] ; Xuemei Huang [États-Unis] | Quantitative susceptibility mapping of the midbrain in Parkinson's disease. |
| 000101 (2015) |
Yusuf Ozgur Cakmak [Turquie] | Provotella-derived hydrogen sulfide, constipation, and neuroprotection in Parkinson's disease. |
| 000102 (2015) |
Maria João Forjaz [Espagne] ; Alba Ayala [Espagne] ; Claudia M. Testa [États-Unis] ; Peter G. Bain [Royaume-Uni] ; Rodger Elble [États-Unis] ; Dietrich Haubenberger [Autriche] ; Carmen Rodriguez-Blazquez [Espagne] ; Günther Deuschl [Allemagne] ; Pablo Martinez-Martin [Espagne] | Proposing a Parkinson's disease-specific tremor scale from the MDS-UPDRS. |
| 000104 (2015) |
Brook Galna [Royaume-Uni] ; Sue Lord ; David J. Burn ; Lynn Rochester | Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype. |
| 000113 (2015) |
David Okai [Royaume-Uni] ; Sally Askey-Jones ; Michael Samuel ; Anthony S. David ; Richard G. Brown | Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease. |
| 000114 (2015) |
Brit Mollenhauer [Allemagne] | Prediagnostic presentation of Parkinson's disease in primary care: A case-control study. |
| 000116 (2015) |
Alfredo Ramirez [Allemagne] | Population-Based Genetic Studies: The Search for Causative Variants in Parkinson's Disease. |
| 000118 (2015) |
Jeff M. Bronstein [États-Unis] ; Kimberly Paul [États-Unis] ; Laurice Yang [États-Unis] ; Richard H. Haas [États-Unis] ; Clifford W. Shults [États-Unis] ; Thuy Le [États-Unis] ; Beate Ritz [États-Unis] | Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease. |
| 000120 (2015) |
Philipp Mahlknecht [Autriche] ; Fabienne Sprenger [Autriche] ; Klaus Seppi [Autriche] ; Werner Poewe [Autriche] | Plasma fasting cholesterol profiles and age at onset in Parkinson's disease. |
| 000121 (2015) |
Christine R. Swanson [États-Unis] ; Yosef Berlyand [États-Unis] ; Sharon X. Xie [États-Unis] ; Roy N. Alcalay [États-Unis] ; Lama M. Chahine [États-Unis] ; Alice S. Chen-Plotkin [États-Unis] | Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients. |
| 000122 (2015) |
Kaviraja Udupa [Canada] ; Susan H. Fox [Canada] | Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD. |
| 000125 (2015) |
Roberta Biundo [Italie] ; Luca Weis ; Silvia Facchini ; Patrizia Formento-Dojot ; Annamaria Vallelunga ; Manuela Pilleri ; Daniel Weintraub ; Angelo Antonini | Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. |
| 000128 (2015) |
Marjan Jahanshahi [Royaume-Uni] ; Ignacio Obeso ; Christelle Baunez ; Manuel Alegre ; Paul Krack | Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity. |
